Hafrun Fridriksdottir

Affiliations

  • Executive Vp, Global R&D at Teva Pharmaceutical Industries Ltd (TEVA), 2022-05-19
  • Svp, Global R&D at Actavis Plc (ACT), 2014-05-13
  • Sr Vp, Global Generics R&D at Actavis Inc. (ACT), 2013-10-03
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
TEVA $8.22 130,000 $1,068,067.00 1,387 2022-05-17 Filing
TEVA $7.37 8,941 $65,865.66 126,087 2022-03-07 Filing
TEVA $7.48 6,618 $49,519.19 111,264 2022-03-04 Filing
TEVA $7.48 18,020 $134,834.65 98,977 2022-03-04 Filing
TEVA $8.14 7,590 $61,799.30 65,509 2022-02-28 Filing